Using the Cre/loxP system we conditionally inactivated β-catenin in endothelial cells. We found that early phases of vasculogenesis and angiogenesis were not affected in mutant embryos; however, vascular patterning in the head, vitelline, umbilical vessels, and the placenta was altered. In addition, in many regions, the vascular lumen was irregular with the formation of lacunae at bifurcations, vessels were frequently hemorrhagic, and fluid extravasation in the pericardial cavity was observed. Cultured β-catenin −/− endothelial cells showed a different organization of intercellular junctions with a decrease in α-catenin in favor of desmoplakin and marked changes in actin cytoskeleton. These changes paralleled a decrease in cell–cell adhesion strength and an increase in paracellular permeability. We conclude that in vivo, the absence of β-catenin significantly reduces the capacity of endothelial cells to maintain intercellular contacts. This may become more marked when the vessels are exposed to high or turbulent flow, such as at bifurcations or in the beating heart, leading to fluid leakage or hemorrhages.
Skip Nav Destination
Article navigation
15 September 2003
Article|
September 15 2003
The conditional inactivation of the β-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility
Anna Cattelino,
Anna Cattelino
1FIRC Institute of Molecular Oncology, 20139 Milan, Italy
2Mario Negri Institute for Pharmacological Research, 20157 Milan, Italy
Search for other works by this author on:
Stefan Liebner,
Stefan Liebner
1FIRC Institute of Molecular Oncology, 20139 Milan, Italy
Search for other works by this author on:
Radiosa Gallini,
Radiosa Gallini
1FIRC Institute of Molecular Oncology, 20139 Milan, Italy
Search for other works by this author on:
Adriana Zanetti,
Adriana Zanetti
2Mario Negri Institute for Pharmacological Research, 20157 Milan, Italy
Search for other works by this author on:
Giovanna Balconi,
Giovanna Balconi
2Mario Negri Institute for Pharmacological Research, 20157 Milan, Italy
Search for other works by this author on:
Alessandro Corsi,
Alessandro Corsi
3Department of Experimental Medicine and Pathology, University La Sapienza, 00185 Rome, Italy
Search for other works by this author on:
Paolo Bianco,
Paolo Bianco
3Department of Experimental Medicine and Pathology, University La Sapienza, 00185 Rome, Italy
Search for other works by this author on:
Hartwig Wolburg,
Hartwig Wolburg
4Institute of Pathology, University of Tübingen, D-72076 Tübingen, Germany
Search for other works by this author on:
Robert Moore,
Robert Moore
5Max Planck Institute of Immunology, 79108 Freiburg, Germany
Search for other works by this author on:
Boussadia Oreda,
Boussadia Oreda
5Max Planck Institute of Immunology, 79108 Freiburg, Germany
Search for other works by this author on:
Rolf Kemler,
Rolf Kemler
5Max Planck Institute of Immunology, 79108 Freiburg, Germany
Search for other works by this author on:
Elisabetta Dejana
Elisabetta Dejana
1FIRC Institute of Molecular Oncology, 20139 Milan, Italy
2Mario Negri Institute for Pharmacological Research, 20157 Milan, Italy
6Department of Genetics, University of Milan, 20122 Milan, Italy
Search for other works by this author on:
Anna Cattelino
1FIRC Institute of Molecular Oncology, 20139 Milan, Italy
2Mario Negri Institute for Pharmacological Research, 20157 Milan, Italy
Stefan Liebner
1FIRC Institute of Molecular Oncology, 20139 Milan, Italy
Radiosa Gallini
1FIRC Institute of Molecular Oncology, 20139 Milan, Italy
Adriana Zanetti
2Mario Negri Institute for Pharmacological Research, 20157 Milan, Italy
Giovanna Balconi
2Mario Negri Institute for Pharmacological Research, 20157 Milan, Italy
Alessandro Corsi
3Department of Experimental Medicine and Pathology, University La Sapienza, 00185 Rome, Italy
Paolo Bianco
3Department of Experimental Medicine and Pathology, University La Sapienza, 00185 Rome, Italy
Hartwig Wolburg
4Institute of Pathology, University of Tübingen, D-72076 Tübingen, Germany
Robert Moore
5Max Planck Institute of Immunology, 79108 Freiburg, Germany
Boussadia Oreda
5Max Planck Institute of Immunology, 79108 Freiburg, Germany
Rolf Kemler
5Max Planck Institute of Immunology, 79108 Freiburg, Germany
Elisabetta Dejana
1FIRC Institute of Molecular Oncology, 20139 Milan, Italy
2Mario Negri Institute for Pharmacological Research, 20157 Milan, Italy
6Department of Genetics, University of Milan, 20122 Milan, Italy
Address correspondence to Elisabetta Dejana, FIRC Institute of Molecular Oncology, Via Adamello, 16-20139, Milan, Italy. Tel.: 39-02-574303-234. Fax: 39-02574303-244. email: [email protected]
The online version of this article includes supplemental material.
Abbreviation used in this paper: E, embryonic day.
Received:
December 24 2002
Accepted:
July 28 2003
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2003
J Cell Biol (2003) 162 (6): 1111–1122.
Article history
Received:
December 24 2002
Accepted:
July 28 2003
Citation
Anna Cattelino, Stefan Liebner, Radiosa Gallini, Adriana Zanetti, Giovanna Balconi, Alessandro Corsi, Paolo Bianco, Hartwig Wolburg, Robert Moore, Boussadia Oreda, Rolf Kemler, Elisabetta Dejana; The conditional inactivation of the β-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility . J Cell Biol 15 September 2003; 162 (6): 1111–1122. doi: https://doi.org/10.1083/jcb.200212157
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement